Gallagher Neil

Director · Officer · FHTX, SNDX, ZYME

As of 2026-09-16, Gallagher Neil has 7 Form 4 transactions on record across 3 companies — 1 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $2.4MIndirect: $0$2.4Mas of 2026-09-16
  • Direct $2.4M
  • Indirect $0
SNDXdirect85,095 sh$1.5M
ZYMEdirect31,000 sh$813K
FHTXdirect28,000 sh$117K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

SNDX · 4 trades
2025-02-10: Sale, 4,618 sh ($72K)2025-02-05: Award / grant, 110,500 sh ($1.6M)2025-02-05: Award / grant, 23,400 sh ($0)2025-02-05: Award / grant, 18,500 sh ($0)
FHTX · 2 trades
2026-06-24: Award / grant, 28,000 sh ($114K)2025-05-01: Award / grant, 50,000 sh ($208K)
ZYME · 1 trade
2024-12-10: Award / grant, 31,000 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2025-02-10SNDXSale4,618 @ $15.50$72K−5.1% of holding85,095Form 4
6 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-06-24FHTXAward / grant28,00028,000Form 4
2025-05-01FHTXAward / grant50,00050,000Form 4
2025-02-05SNDXAward / grant110,500110,500Form 4
2025-02-05SNDXAward / grant23,40089,713Form 4
2025-02-05SNDXAward / grant18,50066,313Form 4
2024-12-10ZYMEAward / grant31,00031,000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.